Trinity Biotech (TRIB) Gains from Investment Securities (2021 - 2024)
Trinity Biotech recorded quarterly Gains from Investment Securities of $7.0 million in Q4 2024, up 169.41% quarter-over-quarter from $2.6 million in Q4 2023, and up 169.41% year-over-year from $2.6 million in Q1 2024.
Trinity Biotech's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at $7.0 million for Q4 2024.
- In Q4 2024, Gains from Investment Securities rose 169.41% year-over-year to $7.0 million; the TTM figure through Dec 2024 stood at $12.5 million (up 145.63% YoY), while the FY2024 annual figure was $2.5 million, up 874.71% from the prior year.
- Gains from Investment Securities came in at $7.0 million for Q4 2024 at Trinity Biotech, up from $2.6 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $7.0 million in Q4 2024 to a low of -$398000.0 in Q3 2022.
- A 4-year average of $2.1 million and a median of $1.3 million in 2022 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities sank 37.57% in 2022 and jumped 169.41% in 2024, its largest moves.
- Trinity Biotech's Gains from Investment Securities stood at $4.9 million in 2021, then plunged by 37.57% to $3.1 million in 2022, then slipped by 15.0% to $2.6 million in 2023, then surged by 169.41% to $7.0 million in 2024.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $7.0 million, $2.6 million, and -$178000.0 for Q4 2024, Q4 2023, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7.01 Mn |
| Dec 31, 2024 | 7.01 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Sep 30, 2023 | -178,000.00 |
| Sep 30, 2023 | -178,000.00 |
| Dec 31, 2022 | 3.06 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Sep 30, 2022 | -398,000.00 |
| Sep 30, 2022 | -398,000.00 |
| Jun 30, 2022 | 995.00 |
| Jun 30, 2022 | 995.00 |
| Dec 31, 2021 | 4.90 Mn |
| Dec 31, 2021 | 4.90 Mn |
| Jun 30, 2021 | -2,774.00 |
| Jun 30, 2021 | -2,774.00 |